Delivery Order SPE2DB22D3301-SPE2DB24FY0EF
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,618.40 contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a COVID-19 treatment medication. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with a ceiling value of $5,010.48 and an ultimate completion date of December 1, 2025. This is a firm fixed-price delivery order awarded without set-aside designation, indicating competitive award based on the vendor's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $20,042.40 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with completion scheduled for January 8, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $12,526.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication. This firm fixed-price delivery order, issued on December 4, 2025, with completion expected by December 26, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,175.40 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Veklury 100 mg vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 100 milligram vials of the COVID-19 treatment medication Veklury (Remdesivir) with a potential value of $13,618.40 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
- This contract award to AmerisourceBergen Drug Corp is a delivery order worth $6,809.20 for the supply of Veklury (remdesivir) 100 mg vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract has an ultimate completion date of October 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds...
- The Defense Logistics Agency Troop Support Medical awarded a $13,606.80 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 mg vials of the antiviral drug VEKLURY (remdesivir). Performance will take place in Conshohocken, Pennsylvania under the terms specified between September 19, 2023 and October 11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor, with no mention of major subcontractors....
- The Defense Logistics Agency Troop Support Medical awarded a $6,803.40 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 mg vials of the antiviral drug VEKLURY (remdesivir). Performance will take place in Conshohocken, Pennsylvania under a September 19, 2023 through October 11, 2023 period of performance. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor, with no mention of major subcontractors. The...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY0EFDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of Veklury (remdesivir) with a potential value of $6,809.20. The award has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is a for-profit prime contractor that provides a wide range of pharmaceutical products and medical supplies to government agencies, particularly the Department of Defense. This delivery order is part of Amerisourcebergen's larger indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver medications and healthcare materials to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 2/6/24 |